New Horizon Longevity Technology Co., Limited occupies a high ground in eye health research and clinical practice, laying out technological innovation in the entire diagnosis and treatment chain.
The product includes Herbal Brightening and Aging Eye Care Liquid, Macular Eye Care Liquid, Eye Moisturizing Spray, etc. Laohua Eye Protection Liquid, a traditional Chinese medicine product under the name of Materia Medica, is the second monomeric product under modern medical technology after artemisinin; Macular eye care solution can alleviate visual impairment caused by macular degeneration; Moisturizing eye spray can prevent eye diseases and relieve visual fatigue.
The drug pipeline has global innovation. The breakthrough drug R&D pipeline includes the herbal Mingmu Laohua Eye Care Liquid 2.0 pipeline, which will benefit patients with diabetes retinopathy or presbyopia, age-related macular degeneration, cataract and glaucoma; The company cooperates with the Hong Kong government and Professor Zhou of the Hong Kong Polytechnic University to develop eye drops and oral supplements to treat diabetes retinopathy and presbyopia; Cooperate with the Hong Kong government and Dean Feng of the School of Traditional Chinese Medicine of the University of Hong Kong to develop drug pipelines for diabetes retinopathy and macular diseases.
Introduction to longevity drugs: NAD+products synthesized from traditional Chinese medicine are undergoing clinical research with the School of Chinese Medicine at the University of Hong Kong.
Some of the company's pipelines have entered the stage of full industrialization and plan to go public in the United States in 2025. After going public, we will use capital market financing to promote the third phase clinical and industrialization of other pipelines